Researchers link death in gene-editing study to a virus used to deliver the treatment, not CRISPR – Metro US

The lone volunteer in a gene-editing study targeting a rare form of Duchenne muscular dystrophy likely died after having a reaction to the virus that delivered the therapy in his body, researchers concluded in an early study. Terry Horgan, 27, of Montour Falls, New York, died last year during one of the first tests of […]

Related Keywords

New York ,United States ,Yale University ,Connecticut ,New York University ,Montour Falls ,Terry Horgan ,Jesse Gelsinger ,Arthur Caplan ,Terence Flotte ,Drug Administration ,Educational Media Group ,Science Department ,York University ,Howard Hughes Medical Institute Science ,University Of Massachusetts Chan Medical School ,Nobel Prize ,Cure Rare Disease ,Rich Horgan ,Massachusetts Chan Medical School ,Cure Rare ,Associated Press Health ,Howard Hughes Medical Institute ,Educational Media ,